Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1952 1
1958 1
1959 1
1960 5
1961 1
1962 1
1963 1
1964 2
1976 3
1977 3
1978 5
1979 29
1980 76
1981 143
1982 182
1983 297
1984 436
1985 767
1986 1003
1987 1464
1988 1617
1989 1779
1990 1682
1991 1890
1992 1849
1993 1786
1994 2144
1995 1905
1996 2047
1997 1880
1998 2195
1999 1897
2000 1927
2001 2111
2002 1964
2003 2003
2004 2010
2005 2154
2006 1925
2007 1795
2008 1827
2009 1743
2010 1669
2011 1655
2012 1605
2013 1551
2014 1529
2015 1473
2016 1398
2017 1234
2018 1247
2019 1249
2020 1254
2021 1235
2022 1165
2023 1085
2024 1058
2025 1154
2026 397
2028 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64,785 results

Results by year

Filters applied: . Clear all
Page 1
[Ciclosporin].
Doutre MS. Doutre MS. Ann Dermatol Venereol. 2002 Apr;129(4 Pt 1):392-404. Ann Dermatol Venereol. 2002. PMID: 12055538 Review. French.
Ciclosporin, produced by the fungus Tolypocladium inflatum GAMS is endowed with potent immunosuppressive properties. ...Ciclosporin provokes serious adverse reactions especially nephrotoxicity and arterial hypertension. ...
Ciclosporin, produced by the fungus Tolypocladium inflatum GAMS is endowed with potent immunosuppressive properties. ...Ciclospori …
Cyclosporine-induced erythromelalgia.
Caiza-Zambrano F, Galarza J, Benetti M, Gonzalez F, Landriscina P, Reisin R, León-Cejas L. Caiza-Zambrano F, et al. Pract Neurol. 2023 Aug;23(4):343-345. doi: 10.1136/pn-2023-003770. Epub 2023 Jun 30. Pract Neurol. 2023. PMID: 37391230
We report a 42-year-old woman who developed erythromelalgia after taking cyclosporine for myasthenia gravis. Although exact mechanism for this rare adverse effect is unclear, it is reversible, and so clinicians should be aware of the association . Additional use of cortico …
We report a 42-year-old woman who developed erythromelalgia after taking cyclosporine for myasthenia gravis. Although exact mechanism …
Cyclophilin inhibitors.
Gallay PA. Gallay PA. Clin Liver Dis. 2009 Aug;13(3):403-17. doi: 10.1016/j.cld.2009.05.002. Clin Liver Dis. 2009. PMID: 19628157 Review.
Cyclosporine analogues.
Jeffery JR. Jeffery JR. Clin Biochem. 1991 Feb;24(1):15-21. doi: 10.1016/0009-9120(91)90105-n. Clin Biochem. 1991. PMID: 2060128 Review.
Numerous analogues of cyclosporine A (CsA) have been produced and studied. Although these analogues have given considerable insight into structure-activity relationships, none have been shown to have the safety and efficacy of CsA. The most promising of these analogues is …
Numerous analogues of cyclosporine A (CsA) have been produced and studied. Although these analogues have given considerable insight i …
[Ciclosporin].
Paul C; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Paul C, et al. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):466-469. doi: 10.1016/j.annder.2019.04.011. Epub 2019 Jun 14. Ann Dermatol Venereol. 2019. PMID: 31204125 French. No abstract available.
Cyclosporine neurotoxicity.
Hauben M. Hauben M. Pharmacotherapy. 1996 Jul-Aug;16(4):576-83. Pharmacotherapy. 1996. PMID: 8840363 Review.
Studies and case reports on cyclosporine neurotoxicity in which individualized patient data were provided were included for review and analysis. ...Postulated mechanisms include a vasculopathy based on cyclosporine's effect on endothelial cell synthesis of pr …
Studies and case reports on cyclosporine neurotoxicity in which individualized patient data were provided were included for review an …
The carcinogenicity of ciclosporin.
Ryffel B. Ryffel B. Toxicology. 1992;73(1):1-22. doi: 10.1016/0300-483x(92)90166-c. Toxicology. 1992. PMID: 1589877 Review.
Experimental data relevant for the evaluation of the carcinogenic potential of the immunosuppressant ciclosporin are reviewed: Firstly, the mode of action of ciclosporin at the level of lymphocyte gene transcription, secondly, the main adverse effects especially nep …
Experimental data relevant for the evaluation of the carcinogenic potential of the immunosuppressant ciclosporin are reviewed: Firstl …
Cyclosporine treatment of glomerular diseases.
Klein M, Radhakrishnan J, Appel G. Klein M, et al. Annu Rev Med. 1999;50:1-15. doi: 10.1146/annurev.med.50.1.1. Annu Rev Med. 1999. PMID: 10073260 Review.
Cyclosporine's efficacy in other glomerulopathies, such as IgA nephropathy (IgAN) and membranoproliferative glomerulonephritis (MPGN) remains poorly studied and, given the risk of nephrotoxicity, cannot be recommended for treatment of these entities until further da …
Cyclosporine's efficacy in other glomerulopathies, such as IgA nephropathy (IgAN) and membranoproliferative glomerulonephritis …
Ciclosporin use during pregnancy.
Paziana K, Del Monaco M, Cardonick E, Moritz M, Keller M, Smith B, Coscia L, Armenti V. Paziana K, et al. Drug Saf. 2013 May;36(5):279-94. doi: 10.1007/s40264-013-0034-x. Drug Saf. 2013. PMID: 23516008 Review.
Ciclosporin (cyclosporine) is an immunosuppressive drug first approved for use in organ transplantation to prevent rejection. ...Medical literature concerning women with autoimmune disorders exposed to ciclosporin during pregnancy are currently limited to cas …
Ciclosporin (cyclosporine) is an immunosuppressive drug first approved for use in organ transplantation to prevent rejection. …
[Cyclosporine and psoriasis].
Mazer JM. Mazer JM. Rev Prat. 1991 Oct 15;41(22):2183-4. Rev Prat. 1991. PMID: 1784921 Review. French.
Cyclosporin has proved efficacious in severe and resistant psoriasis. When moderate doses are administered (below 5 mg/kg/day) satisfactory clinical results are obtained at the cost of side-effects that can be controlled, since they are dose-dependent and regress when dosa …
Cyclosporin has proved efficacious in severe and resistant psoriasis. When moderate doses are administered (below 5 mg/kg/day) satisf …
64,785 results
You have reached the last available page of results. Please see the User Guide for more information.